Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Goossens

Showing results (1-10 of 485) with videos related to

Pageof 49
Sort By:
The Lancet. Infectious Diseases|April 12, 2011
Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in health-care facilitiesHerman Goossens
The Lancet. Infectious Diseases|January 26, 2013
The Chennai declaration on antimicrobial resistance in IndiaHerman Goossens
Nature|February 17, 2017
Shout about the European Union's successHerman Goossens
Chemotherapy|July 12, 2005
European status of resistance in nosocomial infectionsHerman Goossens
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Vancomycin-resistant Enterococcus faecium derived from animals colonizing the human gut: the missing evidence?Herman Goossens
BMJ (Clinical Research Ed.)|October 20, 2007
Antibiotics for respiratory tract infections in primary careSamuel Coenen, Herman Goossens
BMJ (Clinical Research Ed.)|October 4, 2014
Antibiotic treatment failure in primary careSamuel Coenen, Herman Goossens
Drugs|April 21, 2011
European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across EuropePeter Zarb, Herman Goossens
BMJ (Clinical Research Ed.)|May 6, 2006
Community acquired pneumonia in primary careHerman Goossens, Paul Little
Diagnostic Microbiology and Infectious Disease|December 20, 2005
Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004)Herman Goossens, Béatrice Grabein
Pageof 49

Showing results (1-10 of 485) with videos related to

Sort By:
Pageof 49
The Lancet. Infectious Diseases|April 12, 2011
Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in health-care facilitiesHerman Goossens
The Lancet. Infectious Diseases|January 26, 2013
The Chennai declaration on antimicrobial resistance in IndiaHerman Goossens
Nature|February 17, 2017
Shout about the European Union's successHerman Goossens
Chemotherapy|July 12, 2005
European status of resistance in nosocomial infectionsHerman Goossens
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Vancomycin-resistant Enterococcus faecium derived from animals colonizing the human gut: the missing evidence?Herman Goossens
BMJ (Clinical Research Ed.)|October 20, 2007
Antibiotics for respiratory tract infections in primary careSamuel Coenen, Herman Goossens
BMJ (Clinical Research Ed.)|October 4, 2014
Antibiotic treatment failure in primary careSamuel Coenen, Herman Goossens
Drugs|April 21, 2011
European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across EuropePeter Zarb, Herman Goossens
BMJ (Clinical Research Ed.)|May 6, 2006
Community acquired pneumonia in primary careHerman Goossens, Paul Little
Diagnostic Microbiology and Infectious Disease|December 20, 2005
Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004)Herman Goossens, Béatrice Grabein
Pageof 49